image
SAB Biotherapeutics, Inc. SABS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.1
-15.5 %
$ 28.6 M
Market Cap
-0.49
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -90.63% -125.14% -31.67%
Annual Report FY 10-K 2022-12-31 -60.73% -7.43% -115.91%
Annual Report FY 10-K 2021-12-31 10.21% -86.71% -65.15%
Annual Report FY 10-K 2020-12-31 1504.91% 313.62% 337.01%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -102.84% -112.47%
Quarterly Report Q2 8-K 2024-06-30 207.70% -6.61% -57.52%
Quarterly Report Q1 8-K 2024-03-31 62.55% 32.07% -53.89%
Quarterly Report Q4 8-K 2023-12-31 -85.88% -190.26% -140.12%
Quarterly Report Q3 8-K 2023-09-30 -64.69% 19.58% 31.82%
Quarterly Report Q2 8-K 2023-06-30 -98.65% -44.07% 1.01%
Quarterly Report Q1 8-K 2023-03-31 -95.08% -750.41% -10.36%
Quarterly Report Q4 8-K 2022-12-31 -96.45% 55.96% 38.06%
Quarterly Report Q3 8-K 2022-09-30 0.00% -1845.63% -2226.71%
Quarterly Report Q2 8-K 2022-06-30 0.00% -62.36% -127.78%
Quarterly Report Q1 8-K 2022-03-31 0.00% -30.07% -824.07%
Quarterly Report Q4 8-K 2021-12-31 0.00% -198646.33% -140891.02%
Quarterly Report Q3 8-K 2021-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2021-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2021-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2020-12-31 0.00% 0.00% 0.00%